Measurement of cyclooxygenase inhibition in vivo : a study of two non-steroidal anti-inflammatory drugs in sheep

Cheng, Z., Nolan, A.M. and McKellar, Quintin (1998) Measurement of cyclooxygenase inhibition in vivo : a study of two non-steroidal anti-inflammatory drugs in sheep. pp. 353-366. ISSN 1420-908X
Copy

The anti-inflammatory effects of the non-steroidal anti-inflammatory drugs phenylbutazone (PBZ) and flunixin meglumine (FM) and the relationship between the effects and drug concentration in vivo were studied using a subcutaneous tissue-cage model in sheep. Intracaveal injection of carrageenan induced prostaglandin (PG) E-2 production in tissue-cage exudate (maximal concentration, 101 nM) with significant increases in white blood cell (WBC) numbers, skin temperature over the inflamed cage and exudate leukotriene B-4 (LTB4) concentration (P < 0.05). Intravenous PBZ, 4.4 mg kg(-1) produced mild inhibition of exudate PGE(2) generation (10%), but greater inhibition of serum TXB2 (75.3%). The IC50 for TXB2 was 36.0 mu M. Phenylbutazone did not alter effects on skin temperature, WBC numbers or exudate LTB4 concentrations. Intravenous FM, 1.1 mg kg(-1), significantly inhibited carrageenan-induced exudate PGE(2) formation (E-max, 100%, IC50, <0.4 nM) and serum TXB2 generation (E-max, 100%, IC50, 17 nM) for up to 32 h. Flunixin meglumine significantly inhibited the rise in skin temperature but had a limited effect on exudate WBC. Phenylbutazone and FM have distinct effects on carrageenan-induced cyclooxygenase (COX-2) and platelet COX (COX-1). Flunixin meglumine was a more potent COX inhibitor than PBZ and was more selective for the inducible form of COX in vivo.

Full text not available from this repository.

Atom BibTeX OpenURL ContextObject in Span OpenURL ContextObject Dublin Core MPEG-21 DIDL EndNote HTML Citation METS MODS RIOXX2 XML Reference Manager Refer ASCII Citation
Export

Downloads